Systemic and lung-resident memory elicited by OC43 coronavirus infection in mice.

Authors

Nathan L Sanders, Devin Kenney, Neelou S Etesami, Anukul T Shenoy, Konstantinos Kontodimas, Julian Amirault, Chioma Okolo, Viviana A Dominguez, Marc Semaan, Ekaterina Murzin, James A Lederer, Florian Douam, Mohsan Saeed, Joseph P Mizgerd

Published in

Journal of immunology (Baltimore, Md. : 1950). Volume 215. Issue 7. Jul 10, 2026.

Abstract

Endemic coronaviruses circulate seasonally and, while typically mild, can produce robust inflammation and severe pneumonia. Immunological memory to coronaviruses can be cross-reactive for multiple coronaviruses including OC43 and SARS-CoV-2. In this study, we used mouse models to investigate immune responses elicited by pulmonary infection with OC43. OC43 caused a mild, self-limiting infection. Early after infection, there was acute influx of myeloid cells and lymphocytes to the lung as well as a type I interferon-dependent production of IFN-γ. However, blocking interferons did not enhance viral infection. After recovery, lungs contained resident memory lymphocytes, and both the blood and lungs contained antibodies against OC43. When infection was supplemented with proinflammatory stimuli to model more severe disease, OC43-elicited immune changes were bolstered, including increased virus-specific plasma IgG and lung IgA, enhanced lung B-cell class-switching, and increased antigen-specific Th1 and Th17 cytokine production from lung CD4+ T cells. The antibodies and CD4+ T cells in mice recovered from OC43 infection, even with immunostimulatory agents, reacted only with OC43 proteins and peptides and not with those from other coronaviruses. Therefore, OC43 infection in wild-type mice does not induce the heterotypic immunity observed in humans. In conclusion, OC43 induces a self-limiting lung infection in mice accompanied by homotypic lung-resident and systemic memory, amplified by proinflammatory stimuli during infection.

PMID:
42455848
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.